rs12011040
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002025.4(AFF2):c.1488G>A(p.Ser496=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0557 in 1,208,514 control chromosomes in the GnomAD database, including 4,114 homozygotes. There are 20,624 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1779 hom., 4175 hem., cov: 22)
Exomes 𝑓: 0.047 ( 2335 hom. 16449 hem. )
Consequence
AFF2
NM_002025.4 synonymous
NM_002025.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -7.97
Genes affected
AFF2 (HGNC:3776): (ALF transcription elongation factor 2) This gene encodes a putative transcriptional activator that is a member of the AF4\FMR2 gene family. This gene is associated with the folate-sensitive fragile X E locus on chromosome X. A repeat polymorphism in the fragile X E locus results in silencing of this gene causing Fragile X E syndrome. Fragile X E syndrome is a form of nonsyndromic X-linked cognitive disability. In addition, this gene contains 6-25 GCC repeats that are expanded to >200 repeats in the disease state. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant X-148953670-G-A is Benign according to our data. Variant chrX-148953670-G-A is described in ClinVar as [Benign]. Clinvar id is 128281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-148953670-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-7.97 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFF2 | NM_002025.4 | c.1488G>A | p.Ser496= | synonymous_variant | 10/21 | ENST00000370460.7 | NP_002016.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFF2 | ENST00000370460.7 | c.1488G>A | p.Ser496= | synonymous_variant | 10/21 | 5 | NM_002025.4 | ENSP00000359489 | P1 |
Frequencies
GnomAD3 genomes AF: 0.140 AC: 15462AN: 110754Hom.: 1778 Cov.: 22 AF XY: 0.126 AC XY: 4159AN XY: 33010
GnomAD3 genomes
AF:
AC:
15462
AN:
110754
Hom.:
Cov.:
22
AF XY:
AC XY:
4159
AN XY:
33010
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0649 AC: 11878AN: 182894Hom.: 946 AF XY: 0.0556 AC XY: 3750AN XY: 67416
GnomAD3 exomes
AF:
AC:
11878
AN:
182894
Hom.:
AF XY:
AC XY:
3750
AN XY:
67416
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0472 AC: 51804AN: 1097707Hom.: 2335 Cov.: 30 AF XY: 0.0453 AC XY: 16449AN XY: 363105
GnomAD4 exome
AF:
AC:
51804
AN:
1097707
Hom.:
Cov.:
30
AF XY:
AC XY:
16449
AN XY:
363105
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.140 AC: 15489AN: 110807Hom.: 1779 Cov.: 22 AF XY: 0.126 AC XY: 4175AN XY: 33073
GnomAD4 genome
AF:
AC:
15489
AN:
110807
Hom.:
Cov.:
22
AF XY:
AC XY:
4175
AN XY:
33073
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 17, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 21, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 05, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FRAXE Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at